Headshot of Maria Coyle

Maria (Pruchnicki) Coyle, PharmD, FCCP, BCPS, BCACP, CLS

Associate Professor - Clinical

Pharmacy Education and Innovation

210A Parks Hall
(614) 292-1363

Professional Interests

Dr. Coyle is a board-certified ambulatory care pharmacist and pharmacotherapy specialist, focused in the area of cardiac risk reduction and chronic disease prevention. In the College’s Doctor of Pharmacy program, she leads a course in the Concepts in Patient Care (CiPC) sequence and also teaches relevant topics in the Pharmacotherapy (IP) course sequence. She also precepts students in introductory and advanced experiential rotations for both clinical care and academic practice. Dr. Coyle has a passion for teaching and learning and strives to create excellent instructional outcomes by bringing together pedagogical expertise, innovative classroom practices, and student support for application of learning. Dr. Coyle’s scholarly interests align with these priorities: new faculty mentoring, postgraduate training for teaching, and professional learning strategies; also, advancing pharmacy services in specialty cardiovascular and primary care.


Maria C. (Pruchnicki) Coyle, PharmD, FCCP, BCPS, BCACP, CLS is a Clinical Associate Professor in the Division of Pharmacy Education and Innovation at The Ohio State University College of Pharmacy. She received her Bachelor of Pharmacy and Doctor of Pharmacy degrees from The Ohio State University and also completed three years of post-graduate fellowship training in nephrology and pharmacokinetics at the College. Dr. Coyle is an Ohio-licensed pharmacist; she is board-certified in Ambulatory Care and Pharmacotherapy, and a Certified Lipid Specialist. She is a graduate of the American Association of Colleges of Pharmacy Academic Leadership Fellows Program (2013) and has been recognized as a Fellow of the American College of Clinical Pharmacy (2017).

Dr. Coyle’s teaching responsibilities include development, coordination, and instruction on the pharmacist role in public health and disease prevention, cardiac risk reduction, and cardiac-renal-metabolic conditions. She is particularly interested in pedagogies and course design that facilitates student transitions from classroom to applied and life-long learning. During her time at Ohio State, she has been involved in curriculum and course design/redesign, led the College’s Teaching and Learning training program (2009-2017) for postgraduate trainees, and served as Faculty Fellow and lead for the new-faculty mentoring and instructional support programs, for the University’s (now-named) Michael V. Drake Institute for Teaching and Learning (2016-2019). She is a member of the University Senate (2022-2025) and was chairperson of the Council on Academic Affairs (2022-2023).

Dr. Coyle practices as a credentialled Specialty Practice Pharmacist in Ambulatory Care at The Ohio State University Wexner Medical Center, providing collaborative and pharmacy-based disease management services which address all aspects of cardiovascular health, including dyslipidemia, diabetes, hypertension, and smoking cessation. Dr. Coyle’s role on the interprofessional team focuses on prevention education and maximizing evidence-based therapies to optimize patient health and quality of care.  She has participated widely in the postgraduate training and education programs of the College of Pharmacy and Wexner Medical Center, and served as the founding residency program director of the PGY2 Ambulatory Care Pharmacy Residency program (2007 – 2015). In 2008, Dr. Coyle received the inaugural 2008 American College of Clinical Pharmacy New Educator Award. In 2023, Dr. Coyle served as chairperson for the FDA’s Nonprescription Drug Advisory Committee.    

Dr. Coyle’s scholarly work reflects her academic and clinical practice interests, with numerous publications and national/international presentations on scholarship of teaching and learning, pharmacist roles and services in cardiovascular and primary care, and new faculty training and mentoring.  She provides presentations and publications for continuing pharmacist education and training, including programs for the American Pharmacist Association, American Association of Colleges of Pharmacy, the Board of Pharmaceutical Specialties, and Pharmacy Times Continuing Education.  


  • 2021, Certified Lipid Specialist, Accreditation Council for Clinical Lipidology
  • 2021, Board Certified Ambulatory Care Pharmacist, Board of Pharmaceutical Specialties
  • 2018, Board Certified Pharmacotherapy Specialist, Board of Pharmaceutical Specialties
  • 2002, Fellowship in Clinical Pharmacokinetics and Nephrology, The Ohio State University College of Pharmacy
  • 1999, PharmD, Ohio State University
  • 1991, Bachelor of Pharmacy, Ohio State University


  • Sabatino JA, Pruchnicki MC, Sevin AM, Barker E, Green CG, Porter K. Improving prescribing practices: A pharmacist-led educational intervention for nurse practitioner students. J Am Assoc Nurse Pract. 2017 May;29(5):248-254. doi: 10.1002/2327-6924.12446. Epub 2017 Feb 18. PMID: 28213909.
  • Shin TR, Clark Dula CA, Mehta BH, Rodis JL, Pruchnicki MC. Pharmacy residents' pursuit of academic positions. Am J Pharm Educ. 2015 Apr 25;79(3):38. doi: 10.5688/ajpe79338. PMID: 25995513; PMCID: PMC4428423.
  • Rodis JL, Backo J, Schmidt BM, Pruchnicki MC. Student-peer mentoring on a drug information response. Am J Pharm Educ. 2014 Mar 12;78(2):38. doi: 10.5688/ajpe78238. PMID: 24672071; PMCID: PMC3965146.
  • West T, Pruchnicki MC, Porter K, Emptage R. Evaluation of anticholinergic burden of medications in older adults. J Am Pharm Assoc (2003). 2013 Sep- Oct;53(5):496-504. doi: 10.1331/JAPhA.2013.12138. PMID: 24030127.
  • LeBlanc JM, Dasta JF, Pruchnicki MC, Gerlach A, Cook C. Bispectral index values, sedation-agitation scores, and plasma Lorazepam concentrations in critically ill surgical patients. Am J Crit Care. 2012 Mar;21(2):99-105. doi: 10.4037/ajcc2012777. PMID: 22381986.
  • Nahata M, Kelley K, McAuley J, Bennett M, Carnes C, Casper K, Knoell D, Pruchnicki M, Schneider P, Massaro A. Renewing vision and strategic priorities for an academic unit. Am J Pharm Educ. 2010 Feb 10;74(1):13. doi: 10.5688/aj740113. PMID: 20221364; PMCID: PMC2829141.
  • Rodis J, Pruchnicki MC, Casper KA, Bennett MS, Mehta BH. The importance of terminology in the profession of pharmacy. Am J Pharm Educ. 2009 Jul 10;73(4):74. PMID: 19657508; PMCID: PMC2720370.
  • Leiker LL, Mehta BH, Pruchnicki MC, Rodis JL. Risk factors and complications of subconjunctival hemorrhages in patients taking warfarin. Optometry. 2009 May;80(5):227-31. doi: 10.1016/j.optm.2008.10.018. PMID: 19410227.
  • Leiker LL, Mehta BH, Rodis JL, Pruchnicki MC, Pedersen CA. Assessment of pharmacy faculty members' opinions regarding required postgraduate pharmacy residencies. Am J Health Syst Pharm. 2009 Feb 15;66(4):378-88. doi: 10.2146/ajhp070586. PMID: 19202048.
  • Tkacz VL, Metzger A, Pruchnicki MC. Health literacy in pharmacy. Am J Health Syst Pharm. 2008 May 15;65(10):974-81. doi: 10.2146/ajhp070520. PMID: 18463348.